Surgical ablation of atrial fibrillation in patients with congestive heart failure

Herko Grubitzsch1, Simon Dushe, Sven Beholz

  • 1Department of Cardiovascular Surgery, Charité-Universitätsmedizin Berlin, Campus Charité Mitte, Berlin, Germany.

Journal of Cardiac Failure
|September 11, 2007
PubMed

Insights

Surgical ablation for atrial fibrillation (AF) in patients with congestive heart failure (CHF) can improve outcomes, especially for those with severely impaired left ventricular function. Stable sinus rhythm after ablation is associated with superior survival rates.

Area of Science:

  • Cardiology
  • Cardiac Surgery
  • Electrophysiology

Background:

  • Congestive heart failure (CHF) and atrial fibrillation (AF) are comorbid conditions that negatively impact patient morbidity and mortality.
  • These conditions often exacerbate each other, creating a complex clinical challenge.

Purpose of the Study:

  • To evaluate the efficacy and outcomes of surgical ablation for AF in patients with concurrent CHF.
  • To determine if concomitant AF ablation impacts clinical status and survival in CHF patients.

Main Methods:

  • A cohort of 212 patients undergoing left atrial ablation for persistent AF was analyzed.
  • Seventy-nine patients (37.3%) had concomitant CHF, with varying degrees of left ventricular ejection fraction (LVEF) impairment.
  • Outcomes including rhythm control, LVEF, functional class, and survival were compared between CHF patients and controls.

Main Results:

  • Patients with CHF required more circulatory support and longer ICU stays compared to controls.
  • Rhythm control rates at follow-up were similar between CHF patients (66%) and controls (74%).
  • In patients with LVEF ≤ 0.30, successful sinus rhythm conversion significantly improved LVEF, NYHA class, and quality of life; superior survival was observed in patients maintaining stable sinus rhythm.

Conclusions:

  • Concomitant surgical AF ablation should be considered in CHF patients undergoing cardiac surgery.
  • The procedure is particularly beneficial for patients with severely impaired left ventricular function.
  • Achieving and maintaining sinus rhythm post-ablation is linked to improved clinical outcomes and survival in this population.
Abstract

Related Concept Videos

Heart Failure VI: Adjunct Therapies01:22

Heart Failure VI: Adjunct Therapies

Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.
Disturbances in Heart Rhythm01:29

Disturbances in Heart Rhythm

Arrhythmia or dysrhythmia refers to an abnormal heart rhythm caused by a defect in the heart's conduction system. It can cause the heart to beat irregularly, too quickly, or too slowly, leading to symptoms like chest pain, shortness of breath, and fainting. Factors such as stress, caffeine, alcohol, nicotine, cocaine, certain drugs, congenital defects, diseases, and electrolyte abnormalities can trigger arrhythmias.
Arrhythmias are categorized by their speed, rhythm, and origin. A slow heart...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...